81 related articles for article (PubMed ID: 8052967)
1. Covalent linkage of streptokinase to recombinant hirudin: a novel thrombolytic agent with antithrombotic properties.
Phaneuf MD; Ozaki CK; Johnstone MT; Loza JP; Quist WC; LoGerfo FW
Thromb Haemost; 1994 Apr; 71(4):481-7. PubMed ID: 8052967
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of a recombinant hirudin-albumin complex.
Phaneuf MD; Ito RK; LoGerfo FW
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):641-5. PubMed ID: 7841322
[TBL] [Abstract][Full Text] [Related]
3. Covalent linkage of recombinant hirudin to poly(ethylene terephthalate) (Dacron): creation of a novel antithrombin surface.
Phaneuf MD; Berceli SA; Bide MJ; Quist WC; LoGerfo FW
Biomaterials; 1997 May; 18(10):755-65. PubMed ID: 9158859
[TBL] [Abstract][Full Text] [Related]
4. Covalent linkage of recombinant hirudin to a novel ionic poly(carbonate) urethane polymer with protein binding sites: determination of surface antithrombin activity.
Phaneuf MD; Szycher M; Berceli SA; Dempsey DJ; Quist WC; LoGerfo FW
Artif Organs; 1998 Aug; 22(8):657-65. PubMed ID: 9702317
[TBL] [Abstract][Full Text] [Related]
5. Bioengineering of a novel small diameter polyurethane vascular graft with covalently bound recombinant hirudin.
Phaneuf MD; Dempsey DJ; Bide MJ; Szycher M; Quist WC; LoGerfo FW
ASAIO J; 1998; 44(5):M653-8. PubMed ID: 9804516
[TBL] [Abstract][Full Text] [Related]
6. Thrombin inhibition by covalently bound hirudin.
Ito RK; Phaneuf MD; LoGerfo FW
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):77-81. PubMed ID: 1773001
[TBL] [Abstract][Full Text] [Related]
7. In vivo assessment of a novel dacron surface with covalently bound recombinant hirudin.
Wyers MC; Phaneuf MD; Rzucidlo EM; Contreras MA; LoGerfo FW; Quist WC
Cardiovasc Pathol; 1999; 8(3):153-9. PubMed ID: 10722238
[TBL] [Abstract][Full Text] [Related]
8. Mapping of the plasminogen binding site of streptokinase with short synthetic peptides.
Nihalani D; Raghava GP; Sahni G
Protein Sci; 1997 Jun; 6(6):1284-92. PubMed ID: 9194188
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a novel hirudin-coated polyester graft to physiologic flow conditions: hirudin bioavailability and thrombin uptake.
Berceli SA; Phaneuf MD; LoGerfo FW
J Vasc Surg; 1998 Jun; 27(6):1117-27. PubMed ID: 9652474
[TBL] [Abstract][Full Text] [Related]
10. Development of MDL 28,050, a small stable antithrombin agent based on a functional domain of the leech protein, hirudin.
Krstenansky JL; Broersma RJ; Owen TJ; Payne MH; Yates MT; Mao SJ
Thromb Haemost; 1990 Apr; 63(2):208-14. PubMed ID: 2363122
[TBL] [Abstract][Full Text] [Related]
11. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
12. Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae.
Lehman ED; Joyce JG; Bailey FJ; Markus HZ; Schultz LD; Dunwiddie CT; Jacobson MA; Miller WJ
Protein Expr Purif; 1993 Jun; 4(3):247-55. PubMed ID: 8518563
[TBL] [Abstract][Full Text] [Related]
13. A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity--a staphylokinase variant. I. In vitro study.
Szemraj J; Walkowiak B; Kawecka I; Janiszewska G; Buczko W; Bartkowiak J; Chabielska E
J Thromb Haemost; 2005 Oct; 3(10):2156-65. PubMed ID: 16150047
[TBL] [Abstract][Full Text] [Related]
14. A fusion protein with improved thrombolytic effect and low bleeding risk.
Wang X; Zhang G; Wang L; Zhang Q; Qin Y; Wu C; Yu A
Thromb Haemost; 2009 Dec; 102(6):1194-203. PubMed ID: 19967151
[TBL] [Abstract][Full Text] [Related]
15. Interaction of immobilized human plasminogen and plasmin with streptokinase.
Shi GY; Chang BI; Wu DH; Wu HL
Biochem Biophys Res Commun; 1993 Aug; 195(1):192-200. PubMed ID: 8363600
[TBL] [Abstract][Full Text] [Related]
16. Mutation of lysines in a plasminogen binding region of streptokinase identifies residues important for generating a functional activator complex.
Lin LF; Oeun S; Houng A; Reed GL
Biochemistry; 1996 Dec; 35(51):16879-85. PubMed ID: 8988027
[TBL] [Abstract][Full Text] [Related]
17. Isolation of a proteinase with plasminogen-activating activity from Lachesis muta muta (bushmaster) snake venom.
Sanchez EF; Santos CI; Magalhaes A; Diniz CR; Figueiredo S; Gilroy J; Richardson M
Arch Biochem Biophys; 2000 Jun; 378(1):131-41. PubMed ID: 10871053
[TBL] [Abstract][Full Text] [Related]
18. A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo.
Sheffield WP; Eltringham-Smith LJ; Gataiance S; Bhakta V
Thromb Haemost; 2009 May; 101(5):867-77. PubMed ID: 19404540
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of thrombin by hirudin genetically fused to wild-type or mutant antithrombin.
Syed S; Kelly KE; Sheffield WP
Thromb Res; 1996 Dec; 84(6):419-29. PubMed ID: 8987163
[TBL] [Abstract][Full Text] [Related]
20. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
Hérault JP; Bernat A; Gaich C; Herbert M
Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
